Ching-Yang Lin

Securities Offering and other Corporate Finance

• Advised the underwriters of Giga-Byte Technology Co., Ltd. in its $500 million convertible bonds offering
• Advised the underwriters of Phison Electronics in its $800 million convertible bonds offering
• Advised the underwriters of MiTAC in its $330 million convertible bonds offering
• Advised the underwriters of Winbond Electronics Corp. in its $750 million convertible bonds offering

• Advised the underwriters of Wiwynn Corp. in its $2 billion convertible bonds offering, the largest overseas CB offering by a Taiwan-based company in history
• Advised the underwriters of Delton Technology in its $420 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Distinct Healthcare in its $36 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Vanguard International Semiconductor in its $350 million convertible bonds offering
• Advised the placing agents of Fangzhou Inc. in its HK$150 million top-up placement of shares
• Advised the underwriters of Vigonvita Life Sciences in its $76 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Wistron Corporation in its $1.2 Billion convertible bonds offering, the largest overseas CB offering by a Taiwan-based company as of 2025
• Advised OBOOK Holdings Inc. (OwlTing Group) in its direct listing on Nasdaq, the first direct listing by an Asia-based fintech company in the United States
• Advised the underwriters of Zhen Ding Technology on its $400 million convertible bonds offering
• Advised the underwriters of Bizlink Holding Inc. on its $300 million convertible bonds offering
• Advised the underwriters of GenFleet Therapeutics on its $233 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Fortior Technology in its $290 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Eternal Beauty in its $120 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Saint Bella in its $92 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Zhou Liu Fu in its $165 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Wistron Corporation in its $914.25 million GDS offering
• Advised Sichuan Kelun-Biotech Biopharmaceutical in its $250 million proposed placing of new H shares
• Advised the underwriter of Sino-American Silicon in its $284 million GDR offering
• Advised the underwriters of Giga-Byte Technology Co., Ltd. in its concurrent $304 million GDR offering and $300 million convertible bonds offering
• Advised the underwriters of Wiwynn Corp. in its concurrent $837 million GDR offering and $600 million convertible bonds offering
• Advised the underwriters of Fangzhou Inc. on its initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Jiangxi Rimag on its initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Lianlian DigiTech Co., Ltd. on its $84 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Zhen Ding Technology on its $400 million convertible bonds offering
• Advised the initial purchaser of Giga-Byte Technology Co., Ltd. (TPE: 2376) on its $300 million convertible bonds offering
• Advised the underwriters of Sichuan Kelun-Biotech Biopharmaceutical on its $200 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the initial purchasers of Walsin Lihwa Corporation on its $389.1 million GDS offering
• Advised the initial purchasers of PharmaEssentia Corp. on its $462.7 million GDS offering, the largest overseas offering by a Taiwan-based biotech company in history
• Advised the initial purchaser of Bizlink Holding Inc. on its $150 million convertible bonds offering
• Advised the underwriters of Gaush Meditech on its $86 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised AIM Vaccine on its $20 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised the initial purchasers of Taiwan Cement Corporation on its $425 million offering of global depositary shares under Rule 144A and Regulation S
• Advised the initial purchasers and joint bookrunners of Chailease Holding Company Limited on its $388 million GDS offering
• Advised ENN Energy on its $550 million 4.625% green senior notes offering due 2027
• Advised TSMC and its subsidiary on its $3.5 billion SEC-registered debt offering of senior unsecured notes
• Advised Bizlink Holding Inc. on its acquisition financing in connection with its EU451 million acquisition of LEONI AG Industrial Solutions, an electrical appliance assemblies business headquartered in Germany
• Advised China Mobile in its $8.2 billion IPO of A shares and listing on the Main Board of the Shanghai Stock Exchange on Hong Kong and U.S. law matters
• Advised the underwriters of Chervon Holdings on its $462 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Taiwan Cement Corporation (1101.TPE) in its $800 million currency-linked USD denominated zero coupon convertible bonds offering due 2026
• Advised the underwriters of Beijing Airdoc Technology in its $215 million initial public offering of H shares and listing on the Hong Kong Stock Exchange
• Advised TSMC and its wholly-owned subsidiary, TSMC Arizona Corporation, in its $4.5 billion inaugural SEC-registered debt offering of senior unsecured notes
• Advised the underwriters of Hon Hai Precision Industry Co., Ltd. (TPE: 2317) in its offering of $700 million unsecured overseas convertible bonds at negative rate on the Singapore Exchange
• Advised the underwriters of Kindstar Globalgene in its $285.2 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised XPeng in its $2.064 billion global offering and dual-primary listing on the Hong Kong Stock Exchange
• Advised ENN Natural Gas in its offering of five-year $800 million guaranteed senior notes with a coupon of 3.375% through its indirectly wholly owned subsidiary, ENN Clean Energy International Investment Limited
• Advised TSMC Global Ltd., a wholly-owned subsidiary of Taiwan Semiconductor Manufacturing, in its $3.5 billion senior notes offerings
• Advised the underwriters of JOINN Laboratories in its $839 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Alibaba Group in its $5 billion SEC-registered senior notes offering 
• Advised the underwriters of Jacobio Pharmaceuticals in its $195 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of WIN Semiconductors in its $500 million convertible bonds offering
• Advised Oneness Biotech in its $177 million GDR offering
• Advised TSMC Global Ltd., a wholly-owned subsidiary of Taiwan Semiconductor Manufacturing, in its $3 billion senior notes offerings
• Advised CICC and J.P. Morgan as joint financial advisers to Haier Smart Home in its privatization of Haier Electronics Group by way of a scheme of arrangement and simultaneous listing in Hong Kong by way of an introduction
• Advised the underwriters of Hepalink on its $523 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Kangji Medical on its $465 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the initial purchasers and underwriters of Zhen Ding Technology in its $400 million convertible bonds offering
• Advised initial purchasers and joint bookrunners in Innolux Corporation’s $300 million convertible bonds offering
• Advised ECMOHO Limited in its $43.75 million SEC-registered IPO of ADS and listing on NASDAQ
• Advised BioDlink in its $75.3 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised the underwriters of Mulsanne Group in its $112.6 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised IntelliCentrics Global Holdings on its $55.4 million initial public offering and listing on the Hong Kong Stock Exchange
• Advised JP Morgan as bookrunner in Taiwan Cement Corporation’s $400 million overseas unsecured convertible bonds due 2023
• Advised an existing shareholder of BeOne Medicines and a cornerstone investor in BeOne Medicines Ltd.’s $903 million global offering and second primary listing on the Hong Kong Stock Exchange
• Advised JP Morgan, Morgan Stanley and Merrill Lynch as joint bookrunners on Taiwan Cement Corporation’s $549 million offering of global depositary receipts under Rule 144A and Regulation S
• Advised Goldman Sachs on the $64.4 million global offering and listing on the Hong Kong Stock Exchange of AK Medical Holdings Limited
• Advised Bank of America Merrill Lynch, China International Capital Corporation and Credit Suisse on Foxconn Group’s spin-off and listing of its subsidiary Foxconn Interconnect Technology on the Hong Kong Stock Exchange
• Advised New Century Healthcare Holding Co. Limited on its $123 million global offering and listing on the Hong Kong Stock Exchange
• Advised China Oriental in its global cash tender offer and exit consent in relation to the repurchase of its $111 million outstanding senior notes due 2017
• Advised Morgan Stanley and CLSA on the $244 million global offering and listing on the Hong Kong Stock Exchange of Regina Miracle
• Advised the underwriters of Universal Medical Services & Health Management on the $514 million global offering and listing on the Hong Kong Stock Exchange
• Advised underwriters on the $1.1 billion global offering and listing on the Hong Kong Stock Exchange of Fuyao Glass Corporation
• Advised Goldman Sachs and Deutsche Bank on the $220 million global offering and listing on the Hong Kong Stock Exchange of Phoenix Healthcare Group
• Advised Goldman Sachs , Deutsche Bank, Credit Suisse and China International Capital Corporation in connection with Shanghai Pharmaceuticals Holding Co., Ltd.’s $2 billion global offering and listing on the Hong Kong Stock Exchange of H shares
• Advised Nirvana Asia in its $261 million Hong Kong IPO and Rule 144A placement of shares
• Advised the underwriters to Ozner Water International in its $168 million initial public offering and listing in Hong Kong with Rule 144A offering in the United States
• Advised selling shareholders in Alibaba Group’s $25 billion initial public offering and listing on the New York Stock Exchange
• Advised China Merchants Bank on its $5.7 billion rights offering
• Advised the underwriters led by China International Capital Corporation, Credit Suisse, Deutsche Bank, Goldman Sachs and HSBC, on the $3.1 billion IPO and listing in Hong Kong of the People’s Insurance Company (Group) of China Limited
• Advised Citigroup, Deutsche Bank, Goldman Sachs and Morgan Stanley as the joint global coordinators to AIA Group Limited on its $20.5 billion initial public offering of ordinary shares
• Advised Morgan Stanley as the sole bookrunner to China Zenix Auto International Limited on its SEC-registered offering of American depositary shares
• Advised SITC International Holdings Company Limited on its $400 million global offering and listing on the Hong Kong Stock Exchange of ordinary shares
• Advised Alibaba.com Limited on its $1.7 billion global offering and listing on the Hong Kong Stock Exchange of ordinary shares
• Advised a Korean conglomerate on the restructuring of its outstanding debts
• Advising underwriters to debt and warrant offerings under Rule 144A and Regulation S by United Mexican States in the United States
• Advised ChipMOS Technologies (Bermuda) Ltd. on securities offerings, other capital market transactions and mergers and acquisitions, and in connection with ongoing compliance with U.S. securities laws, NASDAQ rules and corporate governance matters

Mergers & Acquisitions

• Advised ProLogium Holding Inc. (Taiwan) in its definitive agreement with Translational Development Acquisition Corp.(U.S.), a SPAC, for a pending de-SPAC transaction and listing on NASDAQ valuing ProLogium at $3.8 billion
• Advised Verdant Solutions in connection with Insight Equity Holdings LLC’s sale of CSAT Solutions to Verdant Solutions
• Advised Nuvoton Technology Corporation on its framework agreement with Tower Semiconductor Ltd. and Tower Partners Semiconductor Co., Ltd. (TPSCo) to implement a strategic restructuring of TPSCo’s business operations
• Advised Innolux’s subsidiary CarUX Holding Limited in its JPY163.6 billion acquisition (enterprise value) of 100% equity interest in Pioneer Corporation from EQT
• Advised Morgan Stanley Asia Limited as financial adviser to Ping An Insurance, acting through an indirect wholly-owned subsidiary (the Offeror), in a proposal to privatize OneConnect Financial Technology Co., Ltd. (6638.HK; OCFT.US) by way of a scheme of arrangement, valuing OneConnect at approximately $310 million
• Advised Morgan Stanley Asia Limited as exclusive financial adviser to Ant Group, acting through its indirect wholly-owned subsidiary (the Offeror), in its unconditional mandatory cash offer for Bright Smart Securities & Commodities Group Limited (1428.HK), valuing Bright Smart at approximately $718 million
• Advised Foxconn Interconnect Technology Limited (6088.HK) in its new $100 million joint venture in Saudi Arabia with a subsidiary of Saleh Suleiman Alrajhi & Sons Co., establishing Smart Mobility SJSC
• Advised Foxconn Interconnect Technology Limited (6088.HK) in connection with FIT Voltaira Group GmbH’s acquisition of Auto-Kabel Group
• Advised IntelliCentrics Global Holdings Ltd. (6819.HK) in the very substantial disposal of its credentialing business in the United States to symplr software LLC, a portfolio company of Clearlake Capital Group, L.P. and Charlesbank for a base purchase price of $246.5 million and its subsequent delisting from the Hong Kong Stock Exchange
• Advised XPeng Inc. in its up to $744 million acquisition of DiDi Global Inc.’s assets and R&D capabilities relating to a new smart electric vehicle model, and related business collaboration arrangements between XPeng and DiDi
• Advised Hon Hai Precision Industry Co., Ltd. (TWSE: 2317) (Foxconn) in its acquisition of 50% shares in ZF Chassis Modules GmbH from ZF Friedrichshafen AG (ZF Group) and establishing a partnership with ZF Group in the field of passenger vehicle chassis systems
• Advised AcBel Polytech Inc. in its acquisition of a 100% stake in ABB Ltd’s Power Conversion division for cash consideration of $505 million
• Advised Foxconn Interconnect Technology Limited (6088.HK) in its acquisition of all equity interests in FIT Voltaira Group GmbH (formerly known as Prettl SWH GmbH) for cash consideration of €186.6 million
• Advised Perfect Corp., a global leader in providing augmented reality and artificial intelligence SaaS solutions, in its de-SPAC transaction with Provident Acquisition Corp., a special purpose acquisition company, valuing the business at $1 billion and resulting in Perfect’s listing on the New York Stock Exchange
• Advised Goldman Sachs in an agreement to sell 188,087,276 shares of Taikang Insurance Group, one of China’s largest insurance and financial services companies, to Credit Suisse AG
• Advised Gogoro in its partnership with Dachangjiang Group and Yadea, China’s leading two-wheel vehicle makers, to deploy a new electric refueling system in China using Gogoro’s battery swapping platform
• Advised Newlinks Technology Limited in its $200 million offering of preferred shares led by Bain Capital and joined by existing investors, bringing Newlinks’ total fundraising to $300 million so far in 2021; and in its $57.2 million series C preferred shares offering and $130 million series D preferred shares offering
• Advised Nuvoton Technology Corporation in its acquisition of the semiconductor business of Panasonic Corporation mainly operated by Panasonic Semiconductor Solutions., Ltd.
• Advised Goldman Sachs in connection with Fountain Medical Development Limiteds $62 million Series D round financing, led by Goldman Sachs, with Lilly Asia Ventures as co-investor
• Advised Foxconn Interconnect Technology in its purchase from Sharp Corporation of certain preferred shares in Kantatsu Co. which represent 28.16% of Kantatsu on a fully diluted basis
• Advised Suning.com in its $1.5 billion sale of ordinary shares of Alibaba Group through Goldman Sachs
• Advised an affiliate of Bitmain Technologies Limited as the lead investor in an $110 million Series E equity investment in Circle Internet Financial Limited
• Advised Spirit AeroSystems in its disposal of equity interest in Taikoo Spirit AeroSystems (Jinjiang) Composite Co., Ltd., a sino-foreign joint venture established by Spirit, HAECO and certain other shareholders, to Hong Kong Aircraft Engineering Company Limited (HAECO)
• Advised Pou Chen Corporation in its proposed $1.39 billion privatization of its indirect Hong Kong-listed subsidiary Pou Sheng International (Holdings) Limited by way of a scheme of arrangement
• Advised Taiwan Cement Corporation and TCC International Limited in their privatization of TCC International Holdings Limited (TCCIH) by way of a scheme of arrangement, valuing TCCIH at $2.55 billion. The first ever share swap between Hong Kong and Taiwan listed companies.
• Advising a China-based PE fund in acquiring the controlling interest in a U.S.-listed, Canada-headquartered company (ongoing)
• Advised Anheuser-Busch InBev on its $1.6 billion sale of SAB Miller’s 49% interest in China Resources Snow Breweries to China Resources Beer
• Advised Taiwan Cement Corporation on its acquisition of minority interest in TCC International Holdings
• Advised the financial advisor of HomeInns on its $1.12 billion going private transaction
• Advised a large-scale family office on its various tranches of financing
• Advised a consortium led by Ally Bridge Group Capital Partners in a definitive agreement and plan of merger with WuXi PharmaTech (Cayman) Inc., pursuant to which the consortium will acquire WuXi PharmaTech at approximately $3.3 billion – one of the largest going-private transactions, as well as one of the largest leveraged buyouts, for a Chinese business
• Advised the special committee of Shanda Games on its $1.9 billion going private transaction
• Advised Suning Commerce Group in its RMB10 billion acquisition financing
• Advised Suning Commerce Group in its sale of a 19.9% stake to Alibaba for $4.3 billion
• Advised Suning Commerce Group in its acquisition of $2.15 billion worth of shares in Alibaba
• Advised a large-scale family office on its formation and $1.9 billion financing
• Advised Credit Suisse, the financial advisor to Bitauto Holdings Limited, on the $1.3 billion investment by JD.com, Inc. and Tencent ‎Holdings Limited in Bitauto
• Advised a consortium of investors, comprising the Carlyle Group, CITIC Capital Partners, CDH Investments, China Everbright Limited and FountainVest Partners, on the $3.7 billion going-private of Focus Media Holding Ltd.
• Advised CST Mining Group on a $505 million sale of its 70% stake in the Mina Justa copper mine in Peru to the Minsur S.A., part of the Breca Group of Peru
• Advised ASE Test Limited on its going-private transaction with Advanced Semiconductor Engineering, Inc.
• Advised a PRC-based PE Fund on taking private of Asia-Info Linkage (did not close)
• Advised Anheuser-Busch InBev NV/SA on its $1.8 billion sale of stakes in Oriental Brewery Co., Ltd. to Kohlberg Kravis Roberts & Co.
• Advised Goldman Sachs on its acquisition of Macquarie IMM Fund Management Company in Korea
• Advised American Express Company on the sale of its 638 million ordinary H shares of Industrial and Commercial Bank of China
• Advised Goldman Sachs Group, Inc. on the sale of its 3 billion ordinary H shares of Industrial and Commercial Bank of China
• Advised Goldman Sachs PIA on its proposed pre-IPO investment in a Taiwanese TV shopping channel operator
• Advised Goldman Sachs PIA on its proposed pre-IPO investment in convertible debt of a Taiwanese touch screen manufacturer
• Advised China Investment Corporation on its $150 million investment in an energy company in the United States
• Advised Goldman Sachs on the $563 million merger of China Water and Drinks Inc. with Heckmann Corporation
• Advised Bank of New York on its $42 billion merger with Mellon Financial Corporation
• Advised Rabobank on its $851 million acquisition of Mid-State Bank & Trust
• Advised R.R. Donnelley & Sons Company on its $1.3 billion acquisition of Banta Corporation, an industry-leading provider of printing and print services and supply chain management services
• Advised R.R. Donnelley & Sons Company on its acquisition of a leading producer of textbooks, testing and supplemental materials
• Advised R.R. Donnelley & Sons Company on its acquisition of a leading provider of printing and print services
• Advised Payless ShoeSource, Inc. on its $91 million acquisition of certain brand development, management and license partnerships
• Advised a multinational universal bank on certain structured finance transactions